Abstract
Deregulated expression of the proto-oncogene c-myb, which results from provirus integration, is thought to be responsible for transformation in a set of murine leukemia virus (MuLV)-induced myeloid leukemias (MML). We reported recently that this transcription factor promotes proliferation by directly transactivating c-myc and inhibits cell death through its up-regulation of Bcl-2 (Schmidt et al., 2000). To understand more about how these cells become transformed we looked at how they deal with cellular pathways inducing growth arrest. Specifically, we were interested in the expression of the tumor suppressor gene Cdkn2b (p15INK4b) in MML because this gene is expressed during myeloid differentiation and its inactivation by methylation has been shown to be important for the development of human acute myeloid leukemia. mRNA levels for p15INK4b and another INK4 gene p16INK4a were examined in monocytic Myb tumors and were compared with expression of the same genes in c-myc transformed monocytic tumors that do not express c-Myb. The Cdkn2a (p16INK4a) gene was generally not expressed in either tumor type, an observation explained by methylation or deletion in the promoter region. Although Cdkn2b (p15INK4b) mRNA was expressed in the Myc tumors, many transcripts were aberrant in size and contained only exon 1. Surprisingly, in the majority of the Myb tumors there was no p15INK4b transcription and neither deletion nor methylation could explain this result. Additional experiments demonstrated that, in the presence of constitutive c-Myb expression, the induction of p15INK4b mRNA that accompanies differentiation of M1 cells to monocytes does not occur. Therefore, the transcriptional regulator c-Myb appears to prevent activation of a growth arrest pathway that normally accompanies monocyte maturation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amanullah A, Hoffman B, Liebermann DA . 2000 Blood 96: 475–482
Amanullah A, Liebermann DA, Hoffman B . 2000 Oncogene 19: 2967–2977
Badley JE, Bishop GA, St John T, Frelinger JA . 1988 Biotechniques 6: 114–116
Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL . 1997 Cancer Res. 57: 832–836
Bies J, Hoffman B, Amanullah A, Giese T, Wolff L . 1996 Oncogene 12: 355–363
Bies J, Mukhopadhyaya R, Pierce J, Wolff L . 1995 Cell Growth Differ. 6: 59–68
Cameron EE, Baylin SB, Herman JG . 1999 Blood 94: 2445–2451
Cogswell JP, Cogswell PC, Kuehl WM, Cuddihy AM, Bender TM, Engelke U, Marcu KB, Ting JP . 1993 Mol. Cell Biol. 13: 2858–2869
Drexler HG . 1998 Leukemia 12: 845–859
Evans JL, Moore TL, Kuehl WM, Bender T, Ting JP . 1990 Mol. Cell Biol. 10: 5747–5752
Frampton J, Ramqvist T, Graf T . 1996 Genes Dev. 10: 2720–2731
Goda SK, Minton NP . 1995 Nucl. Acids Res. 23: 3357–3358
Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L . 1983 Mol. Cell Biol. 3: 787–795
Hannon GJ, Beach D . 1994 Nature 371: 257–261
Herman JG, Jen J, Merlo A, Baylin SB . 1996 Cancer Res. 56: 722–727
Hirama T, Koeffler HP . 1995 Blood 86: 841–854
Hogg A, Schirm S, Nakagoshi H, Bartley P, Ishii S, Bishop JM, Gonda TJ . 1997 Oncogene 15: 2885–2898
Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, Cordon-Cardo C, Barbacid M . 2000 EMBO J. 19: 3496–3506
Liebermann DA, Hoffman-Liebermann B . 1989 Oncogene 4: 583–592
Malumbres M, Perez DC, I, Hernandez MI, Jimenez M, Corral T, Pellicer A . 2000 Mol. Cell Biol. 20: 2915–2925
Malumbres M, Perez DC, I, Santos J, Melendez B, Mangues R, Serrano M, Pellicer A, Fernandez-Piqueras J . 1997 Oncogene 14: 1361–1370
Nason-Burchenal K, Wolff L . 1993 Proc. Natl. Acad. Sci. USA 90: 1619–1623
Oh IH, Reddy EP . 1999 Oncogene 18: 3017–3033
Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ, Serrano M . 1995 Oncogene 11: 635–645
Ragione FD, Iolascon A . 1997 Leuk. Lymphoma 25: 23–35
Ratajczak MZ, Perrotti D, Melotti P, Powzaniuk M, Calabretta B, Onodera K, Kregenow DA, Machalinski B, Gewirtz AM . 1998 Blood 91: 1934–1946
Schmidt M, Nazarov V, Stevens L, Watson R, Wolff L . 2000 Mol. Cell Biol. 20: 1970–1981
Schwaller J, Pabst T, Koeffler HP, Niklaus G, Loetscher P, Fey MF, Tobler A . 1997 Leukemia 11: 54–63
Selvakumaran M, Liebermann DA, Hoffman-Liebermann B . 1992 Mol. Cell. Biol. 12: 2493–2500
Seoane J, Pouponnot C, Staller P, Schader Eilers M, Massagué J . 2001 Nature Cell Biol. 3: 400–408
Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA . 1996 Cell 85: 27–37
Shen-Ong GL, Wolff L . 1987 J. Virol. 61: 3721–3725
Siebert R, Willers CP, Opalka B . 1996 Leuk. Lymphoma 23: 505–520
Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Möröy T, Bartek J, Massagué J, Hänel F, Eilers M . 2001 Nature Cell Biol. 3: 392–399
Taylor D, Badiani P, Weston K . 1996 Genes Dev. 10: 2732–2744
Teofili L, Rutella S, Chiusolo P, La Barbera EO, Rumi C, Ranelletti FO, Maggiano N, Leone G, Larocca LM . 1998 Exp. Hematol. 26: 1133–1139
Thompson EB . 1998 Ann. Rev. Physiol. 60: 575–600
Weinberg RA . 1997 Cell 88: 573–575
Wolff L . 1996 Crit. Rev. Onco. 7: 245–260
Wolff L, Koller R, Bies J, Nazarov V, Hoffman B, Amanullah A, Krall M, Mock B . 1996 Curr. Topics Microbiol. Immunol. 211: 191–199
Wolff L, Koller R, Davidson W . 1991 J. Virol. 65: 3607–3616
Wolff L, Mushinski JF, Shen-Ong GL, Morse III HC . 1988 J. Immunol. 141: 681–689
Zhang B, Peng Z . 2000 J. Mol. Biol. 299: 1121–1132
Zhang S-L, DuBois W, Ramsay ES, Bliskovski V, Morse III HC, Taddesse-Heath L, Vass WC, DePinho R, Mock BA . 2001 Mol. Cell Biol. 21: 310–318
Zobel A, Kalkbrenner F, Vorbrueggen G, Moelling K . 1992 Biochem. Biophys. Res. Commun. 186: 715–722
Acknowledgements
We thank Douglas Lowy and Beverly Mock for critical reading of the manuscript. We also thank Elizabeth E Cameron and J Mikovits for helpful advice in using the bisulphite genomic sequencing protocol and Frank Ruscetti for providing us with the cell line KG1a. We are grateful to Dan Liebermann and Beverly Mock for kindly providing us with Cdkn2 cDNA probes for p16INK4a and p15INK4b.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmidt, M., Koller, R., Haviernik, P. et al. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15INK4b normally associated with differentiation. Oncogene 20, 6205–6214 (2001). https://doi.org/10.1038/sj.onc.1204821
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204821